Mild cognitive disorders in chronic kidney disease: clinical spectrum, pathogenesis, risk factors, treatment


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Обсуждаются взаимосвязи хронической болезни почек и умеренных когнитивных расстройств, реализующиеся в т. ч. через общие факторы риска.

Full Text

Restricted Access

References

  1. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. American Journal of Kidney Diseases 2002;39(2):5—266.
  2. Clase C.M., Garg A.X., Kiberd B.A. Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANESIII). J. Am. Soc. Nephrol. 2002; 13 (5): 1338-1349.
  3. Кутырина И.А. Ремоделирование сосудов при хронической почечной недостаточности. В кн.: Мухин Н.А. (ред.) Нефрология. Национальное руководство. М., “Гэотар-Медиа”. 2009: 608-616.
  4. Helmer C., Stengel B., Metzger M. et al. Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study. Neurology. 2011; 77(23): 2043-2051.
  5. Etgen T., Chonchol M., Förstl H. et al. Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis. Am. J. Nephrol. 2012; 35(5):474-482.
  6. Vogels S.C., Emmelot-Vonk M.H., Verhaar H.J. et al. The association of chronic kidney disease with brain lesions on MRI or CT: a systematic review. Maturitas. 2012; 71(4): 331-336.
  7. Raphael K.L., Wei G., Greene T. et al. Cognitive function and the risk of death in chronic kidney disease. Am. J. Nephrol. 2012; 35(1): 49-57.
  8. Clozer M., Kuhn H., Hefti F. et al. Endothelial dysfunction and subendothelial monocyte macrophages in hypertension. Effect of angiotensin converting enzyme inhibition. Hypertension 1991;18(2): 132-141.
  9. Kurella M., Mapes D.L., Port F.K. et al. Correlates and outcomes of dementia among dialysis patients: the Dialysis Outcomes and Practice Patterns Study. Nephrol. Dial. Transplant. 2006; 21: 2543-2548.
  10. Pereira A.A., Weiner, D.E., Scott T. et al. Cognitive function in dialysis patients. Am. J. Kidney Dis. 2005;45: 448-462.
  11. Hailpern S.M., Melamed M.L., Cohen H.W. et al. Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III). J. Am. Soc. Nephrol. 2007;18:2205-2213.
  12. Burn D.J., Bates D. Neurology and the kidney. J. Neurol. Neurosurg. Psychiatry. 1998;65:810-821.
  13. Штульман Д.Р., Левин О.С. Умеренные когнитивные нарушения. Неврология. Справочник практического врача. М.: Медпресс-информ. 2005;226-229.
  14. Янсен В., Брукнер Г.В. Лечение хронической цереброваскулярной недостаточности с использованием драже актовегин-форте (двойное слепое плацебо-контролируемое исследование). РМЖ. 2002; 12-13:543-546.
  15. American Psychiatry Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Ed. Washington: American Psychiatry Association. 1994.
  16. Левин О.С., Голубева Л.В. Гетерогенность умеренного когнитивного расстройства: диагностические и терапевтические аспекты. Консилиум. 2006;12:106-110.
  17. Yaffe K., Ackerson L., Kurella Tamura M. et. al. Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J. Am. Geriatr. Soc. 2010;58(2):338-345.
  18. Khatri M., Nickolas T., Moon Y.P. et al. CKD Associates with Cognitive Decline. J. Am. Soc. Nephrol. 2009;20(11):2427-2432.
  19. Kurella M., Yaffe K., Shlipak M.G. et al. Chronic kidney disease and cognitive impairment in menopausal women. Am. J. Kidney Dis. 2005;45:66-76.
  20. Elias M.F., Elias P.K., Seliger S.L. et al. Chronic kidney disease, creatinine and cognitive functioning. Nephrol. Dial. Transplant. 2009; 24: 2446-2452.
  21. Jassal S.K., Kritz-Silverstein D., Barrett-Connor E. A Prospective Study of Albuminuria and Cognitive Function in Older Adults. Am. J. Epidemiol. 2010;171(3): 277-286.
  22. Barzilay J.I., Fitzpatrick A.L., Luchsinger J. et al. Albuminuria and dementia in the elderly: a community study. Am. J. Kidney Dis. 2008;52(2):216-226.
  23. Kurella Tamura M., Muntner P., Wadley V. et al. Albuminuria, Kidney Function, and the Incidence of Cognitive Impairment Among Adults in the United States. Am. J. Kidney Dis. 2011.
  24. Kaindl A.M., Sifringer M., Koppelstaetter A. et al. Erythropoietin protects the developing brain from hyperoxia-induced cell death and proteome changes. Ann. Neurol. 2008;64:523-534.
  25. Marshall R.S., Sacco R.L., Kreuger R. et al. Dissociated vertical nystagmus and internuclear ophthalmoplegia from a midbraininfarction. Arch. Neurol. 1991;48:1304-1305.
  26. Дамулин И.В. Патогенетические, диагностические и терапевтические аспекты сосудистых когнитивных нарушений. Consilium Medicum. 2006;8:80-85.
  27. Cottone S., Mulè G., Guarneril M. et al. Endothelin-1 and F2-isoprostane relate to and predict renal dysfunction in hypertensive patients. Nephrol. Dial. Transplant. 2008;24:497-503.
  28. Pratico D., Clark C.M., Liun F. et al. Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch. Neurol. 2002;59(6):972-976.
  29. Sastre M., Calero M., Pawlik M. et al. Binding of cystatin C to Alzheimer’s amyloid beta inhibits in vitro amyloid fibril formation. Neurobiol. Aging 2004;25:1033-1043.
  30. Yaffe K., Lindquist K., Shlipak M.G. et al. Cystatin-C as a Marker of Cognitive Function in Elders: Findings from the Health ABC Study. Ann Neurol. 2008;63(6):798-802.
  31. Mahoney C.A., Arieff A.I. Central and peripheral nervous system effects of chronic renal failure. Kidney Int. 1983;24:170-177.
  32. Agganis B.T., Weiner D.E., Giang L.M. et. al. Depression and Cognitive Function in Maintenance Hemodialysis Patients. Am. J. Kidney. Dis. 2010;56(4):704-712.
  33. Батюшин М.М., Постникова Е.С., Терентьев В.П. и др. Коррекция цереброренальных взаимоотношений при артериальной гипертензии, осложненной ишемическим инсультом: эффективность фиксированной комбинации эпросартана мезилата и гидрохлортиазида. Клиническая нефрология. 2009;1:59-61.
  34. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358(9287):1033-1041.
  35. Yusuf S., Sleight P., Pogue J. et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 2000;342: 145-153.
  36. Dahlof B., Devereux R., Kjeldsen S. et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995-1003.
  37. Baigent C., Keech A., Kearney P.M. et al. Efficacy and safety of cholesterollowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005; 366:1267-1278.
  38. Fourth Joint Task Force Of The European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur. Heart J. 2007;28:2375-2414.
  39. Захаров В.В., Яхно Н.Н. Когнитивные расстройства в пожилом и старческом возрасте. Методическое пособие для врачей. М., 2005:60-66.
  40. Petersen R.C., Stevens J.C., Ganguli M. et al. Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1-1133.
  41. Feng L., Bee Yap K., Pin Ng T. Depressive symptoms in older adults with chronic kidney disease: mortality, quality of life outcomes, and correlates. Am. J. Geriatr. Psychiatry.
  42. Jain N., Trivedi M.H., Rush A.J. et al. Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST). Contemp Clin Trials. 2012;34(1):136-144.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies